We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNN icon
1451
Lindsay Corp
LNN
$1.18B
$4.62M ﹤0.01%
31,996
-282
-0.9% -$37.7K
HP icon
1452
Helmerich & Payne
HP
$4.43B
$4.59M ﹤0.01%
302,834
+4,502
+2% +$82.5K
CRGY icon
1453
Crescent Energy
CRGY
$4.05B
$4.59M ﹤0.01%
533,584
+33,497
+7% +$293K
KN icon
1454
Knowles
KN
$3.33B
$4.58M ﹤0.01%
259,883
+3,009
+1% +$48.6K
HBI
1455
DELISTED
Hanesbrands
HBI
$4.58M ﹤0.01%
999,683
+12,042
+1% +$58.1K
AI icon
1456
C3.ai
AI
$1.57B
$4.57M ﹤0.01%
186,157
+23,187
+14% +$530K
SRPT icon
1457
Sarepta Therapeutics
SRPT
$1.89B
$4.57M ﹤0.01%
267,314
+2,070
+0.8% +$88.3K
NGVT icon
1458
Ingevity
NGVT
$2.61B
$4.56M ﹤0.01%
105,874
+4,116
+4% +$159K
PGNY icon
1459
Progyny
PGNY
$2B
$4.56M ﹤0.01%
207,362
-4,593
-2% -$101K
UEC icon
1460
Uranium Energy
UEC
$5.64B
$4.56M ﹤0.01%
670,479
+71,084
+12% +$398K
EBC icon
1461
Eastern Bankshares
EBC
$5.42B
$4.55M ﹤0.01%
298,282
+11,635
+4% +$175K
FRSH icon
1462
Freshworks
FRSH
$3.44B
$4.54M ﹤0.01%
304,802
-20,902
-6% -$301K
NVO
1463
Novo Nordisk
NVO
$202B
$4.52M ﹤0.01%
65,556
+2,017
+3% +$137K
WSBC icon
1464
WesBanco
WSBC
$4.12B
$4.52M ﹤0.01%
142,925
+9,166
+7% +$277K
ARR
1465
Armour Residential REIT
ARR
$2.38B
$4.51M ﹤0.01%
268,293
+79,501
+42% +$1.28M
SHC icon
1466
Sotera Health
SHC
$5.4B
$4.48M ﹤0.01%
402,749
+7,959
+2% +$93.2K
SAM icon
1467
Boston Beer
SAM
$1.9B
$4.47M ﹤0.01%
23,430
-1,699
-7% -$391K
SI
1468
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$4.47M ﹤0.01%
34,653
+126
+0.4% +$16.2K
TNC icon
1469
Tennant Co
TNC
$1.17B
$4.46M ﹤0.01%
57,567
+1,255
+2% +$92.7K
CBRL icon
1470
Cracker Barrel
CBRL
$1.29B
$4.46M ﹤0.01%
73,014
+1,525
+2% +$76.9K
PRCT icon
1471
Procept Biorobotics
PRCT
$1.24B
$4.46M ﹤0.01%
77,384
+13,011
+20% +$736K
ADEA icon
1472
Adeia
ADEA
$3.31B
$4.45M ﹤0.01%
314,831
+6,230
+2% +$80.6K
SRRK icon
1473
Scholar Rock
SRRK
$6.36B
$4.44M ﹤0.01%
125,381
+4,629
+4% +$145K
RELY icon
1474
Remitly
RELY
$5.55B
$4.44M ﹤0.01%
236,345
+16,643
+8% +$346K
INTA icon
1475
Intapp
INTA
$3.07B
$4.42M ﹤0.01%
85,641
+7,243
+9% +$396K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.